CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: A phase III randomized multicenter study

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 24, Issue 4, 2001, Pages 323-327

  Ron, Ilan G ^a,i   Wigler, Nely ^a   Borovik, Riva ^b   Brufman, George ^c   Rizel, Shulamith ^d   Shani, Adi ^e   Brenner, Joseph ^f   Farbstein, Hannan ^g   Dale, Ari ^g   Inbar, Moshe J ^a   Brenner, Harold J ^d   Chaitchik, Samario ^j   Catane, Raphael ^h  

^a TEL AVIV UNIVERSITY   (Israel)

^b Rambam Northern Israel Medical Centre   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

^e KAPLAN MEDICAL CENTER   (Israel)

^f WOLFSON MEDICAL CENTER   (Israel)

^g Israel Cancer Research Foundation   (Israel)

^h SHAARE ZEDEK MEDICAL CENTER   (Israel)

ⁱ TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^j NONE

more..

Author keywords

Adjuvant chemotherapy; Mitoxantrone; Stage II breast cancer

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; MITOXANTRONE;

ADULT; AGED; ALOPECIA; ARTICLE; BONE MARROW TOXICITY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; METHOTREXATE; MIDDLE AGED; MITOXANTRONE; NEOPLASM STAGING; SURVIVAL ANALYSIS;

EID: 0034906759     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200108000-00001     Document Type: Article

References (14)

1. Mitoxantrone: Its development and role in clinical practice
2. Experimental drugs: Death in the search for cures
3. Antineoplastic agents. Structure-activity relationship of bis(substituted aminoalkylamino) anthraquinones
4. Mitoxantrone, methotrexate, and 5-fluorouracil combination chemotherapy as first-line treatment in stage IV breast cancer
5. Mitoxantrone and cyclophosphamide in advanced breast cancer: A pilot study
6. Randomized trial comparing mitoxantrone with adriamycin in advanced breast cancer
7. Use of mitoxantrone-based combination chemotherapy regimens as first-line treatment for advanced breast cancer
8. A randomised comparative trial of mitoxantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5FU (CMF) in the treatment of advanced breast cancer
9. Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormone unresponsive metastatic breast cancer
10. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer
11. Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients
12. A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer
13. A preliminary report of a pilot randomised trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil with cyclophosphamide, mitoxantrone and 5-fluorouracil in the adjuvant therapy of stage II breast cancer with four or more positive axillary nodes